Sudarshan Pharma Industries Ltd — Important, 12-06-2026: Company Update

Sudarshan Pharma Industries' Warrants Committee approved the allotment of 90 lakh new equity shares to promoter entities. These shares, with a face value of Re.1 each and an issue price of Rs.16.983 (post sub-division), were issued upon conversion of 9 lakh warrants. The company received Rs.11.46 crore, representing the remaining 75% of the warrant issue price. This conversion increases the company's paid-up capital to Rs.24.97 crore, comprising 24.97 crore equity shares. Promoter shareholding now stands at 58.93%. This move strengthens the company's equity base and reflects promoter commitment.